论文部分内容阅读
Protein tyrosine phosphatase(PTP) 1B is a potential therapeutic target for type 2 diabetes.Due to the positively charged nature of its catalytic site,PTP1B is an intractable target for drug discovery and the achievement of in vivo activity is one of the major bottlenecks.